82779-14-4Relevant articles and documents
Preparation and properties of fluorescent glycosaminoglycuronans labeled with 5-aminofluorescein.
Ogamo,Matsuzaki,Uchiyama,Nagasawa
, p. 69 - 85 (1982)
The uronic acid residues of all known glycosaminoglycuronans reacted with 5-aminofluorescein to yield fluorescent glycosaminoglycuronan derivatives, which showed fluorescence characteristics identical to those of fluorescein or 5-acetamidofluorescein. The fluorescent products could be purified by chromatography on Octyl-Sepharose; three preparations of labeled chondroitin 6-sulfate having different degrees of substitution, and a labeled heparin were obtained. Fluorescent hyaluronic acid containing labeled and unlabeled molecules was digested with testicular hyaluronidase to give fluorescent oligosaccharides. Fluorescent chondroitin 6-sulfate was treated with chondroitinase AC to give a nonfluorescent disaccharide and minor proportion of fluorescent octasaccharide. Fluorescent heparin retained its anticoagulant activity, which was similar to that of the starting heparin; its half-life in circulating rabbit blood was 36 min (by fluorometry) and 45 min (by clotting-time assay).
Fluorescein Derivatives as Bifunctional Molecules for the Simultaneous Inhibiting and Labeling of FTO Protein
Wang, Tianlu,Hong, Tingting,Huang, Yue,Su, Haomiao,Wu, Fan,Chen, Yi,Wei, Lai,Huang, Wei,Hua, Xiaoluan,Xia, Yu,Xu, Jinglei,Gan, Jianhua,Yuan, Bifeng,Feng, Yuqi,Zhang, Xiaolian,Yang, Cai-Guang,Zhou, Xiang
supporting information, p. 13736 - 13739 (2016/01/15)
The FTO protein is unequivocally reported to play a critical role in human obesity and in the regulation of cellular levels of m6A modification, which makes FTO a significant and worthy subject of study. Here, we identified that fluorescein der
